Trademark Attorney / Law Firm
Brian N. Lewandowski, Esq. – Trademark Portfolio
Brian N. Lewandowski, Esq. specializes in Class 44 (Medical Services) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 2 total filings concentrated in this category. The practice also covers Class 31 (Natural Agricultural Products) along with 2 other Nice Classification classes. Filing activity spans from 2017 to 2019. Currently, 1 trademark is registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Brian N. Lewandowski, Esq.'s trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademark applications has Brian N. Lewandowski, Esq. filed?
Brian N. Lewandowski, Esq. has filed 2 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 1 abandoned.
What trademark classes does Brian N. Lewandowski, Esq. specialize in?
Brian N. Lewandowski, Esq. has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 44 (Medical Services), Class 31 (Natural Agricultural Products). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
How long has Brian N. Lewandowski, Esq. been filing trademarks?
Brian N. Lewandowski, Esq.'s trademark filing history with the USPTO spans from 2017 to 2019, covering 2 years of trademark practice. During this period, Brian N. Lewandowski, Esq. has handled 2 trademark applications.
What is Brian N. Lewandowski, Esq.'s trademark registration success rate?
Brian N. Lewandowski, Esq. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.